Elevance Health, Inc.
Close on Nov 2, 2026Market cap $89.70BP/E 18.4Yield –
Elevance Health Total Reportable Segments — GAAP Operating Gain by Year
Total Reportable Segments — GAAP Operating Gain ($M)
Elevance Health Total Reportable Segments — GAAP Operating Gain: $7,199M in FY2025, down 8.4% from a year earlier.
Where the FY2025 figure comes from
“|| Total Operating Gain 1,4 | $309 | $673 | (54.1 | %) | $7,199 | $7,862 | (8.4 | %)”
Source: 8-K ER (FY2025Q4, 2026-01-28) ↗
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total Reportable Segments — GAAP Operating Gain ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 7,199 | -8.4% | 8-K ER (FY2025Q4, 2026-01-28) ↗ |
| FY2024 | Dec 31, 2024 | 7,862 | -7.5% | 8-K ER (FY2025Q4, 2026-01-28) ↗ |
| FY2023 | Dec 31, 2023 | 8,499 | +2.6% | 8-K ER (FY2024Q4, 2025-01-23) ↗ |
| FY2022 | Dec 31, 2022 | 8,283 | -2.0% | 8-K ER (FY2023Q4, 2024-01-24) ↗ |
| FY2021 | Dec 31, 2021 | 8,452 | +32.9% | 8-K ER (FY2022Q4, 2023-01-25) ↗ |
| FY2020 | Dec 31, 2020 | 6,360 | – | 8-K ER (FY2021Q4, 2022-01-26) ↗ |
Breakdown
What makes up total Reportable Segments — GAAP Operating Gain
- Total Reportable Segments — Adjusted Operating Gain (Non-GAAP)7,462 · FY2025
- Non-GAAP Adjustment Items to Reportable Segments Operating Gain263 · FY2025
- Health Benefits Segment — GAAP Operating Gain (Loss)6,243 · FY2025
- Total Carelon — GAAP Operating Gain3,378 · FY2025
- Corporate & Other — Unallocated Operating Loss-337 · FY2025
Cite this data
StockData. (2026). Elevance Health Total Reportable Segments — GAAP Operating Gain ($M), annual FY2020–FY2025 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/seg-op-gain-consolidated-total
See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.